Endocrinology, Vol 130, 3617-3624, Copyright © 1992 by Endocrine Society

ARTICLES

Endothelin inhibits osteoclastic bone resorption by a direct effect on cell motility: implications for the vascular control of bone resorption

AS Alam, A Gallagher, V Shankar, MA Ghatei, HK Datta, CL Huang, BS Moonga, TJ Chambers, SR Bloom and M Zaidi
Department of Cellular and Molecular Sciences, St. George's Hospital Medical School, London, United Kingdom.

The abundance of endothelin (ET)-producing endothelial cells in bone marrow and the proximity of these cells to bone-resorbing osteoclasts prompted us to evaluate the action of ET-1 on osteoclast function. Osteoclasts disaggregated from neonatal rat long bones were settled onto devitalized cortical bone substrate, and resorption was quantified by morphometry. The supernatant tartrate-resistant acid phosphatase activity was determined by a spectrophotometric method using paranitrophenol phosphate as substrate. Cell motility was quantified by time lapse video- and computer-assisted image processing using an empirical procedure for morphometric analysis. Cytosolic free calcium levels ([Ca2+]i) were measured in single cells by an indo 1-based microspectrofluorimetric method. Using the area of bone resorbed per slice as response, we found that ET-1 caused a significant (P = 0.011) concentration-dependent inhibition of osteoclastic bone resorption (EC50 = 2.5 nM) without inhibiting acid phosphatase secretion. Exposure of isolated osteoclasts to ET-1 also led to a marked concentration- dependent inhibition of osteoclast motility (EC50 = 7.9 nM; P = 0.013; t1/2 = 18 min) without significant effects on cell spread area. These effects of ET-1 were reversible after removing the peptide, and the cells remained viable during the experiments. In addition, ET-1 did not elevate [Ca2+]i at the concentrations tested. The results suggest that ET-1 specifically interacts with an osteoclast receptor to inhibit osteoclastic bone resorption and cell motility. As the concentration of ET-1 required for osteoclast inhibition was similar to that reported for smooth muscle contraction, it is possible that ET-1, produced locally from the bone marrow endothelial cell, might play a primary role in osteoclast regulation.

This article has been cited by other articles:

				S. Sprogar, J. Volk, M. Drevensek, and G. Drevensek The effects of TBC3214, a selective endothelin ETA receptor antagonist, on orthodontic tooth movement in rats Eur J Orthod, December 1, 2007; 29(6): 605 - 608. [Abstract] [Full Text] [PDF]

				B. Nardelli, L. Zaritskaya, W. McAuliffe, Y. Ni, C. Lincoln, Y. H. Cho, C. E. Birse, W. Halpern, S. Ullrich, and P. A. Moore Osteostat/Tumor Necrosis Factor Superfamily 18 Inhibits Osteoclastogenesis and Is Selectively Expressed by Vascular Endothelial Cells Endocrinology, January 1, 2006; 147(1): 70 - 78. [Abstract] [Full Text] [PDF]

				R. D. Loberg, C. J. Logothetis, E. T. Keller, and K. J. Pienta Pathogenesis and Treatment of Prostate Cancer Bone Metastases: Targeting the Lethal Phenotype J. Clin. Oncol., November 10, 2005; 23(32): 8232 - 8241. [Abstract] [Full Text] [PDF]

				J. J. Yin, K. S. Mohammad, S. M. Kakonen, S. Harris, J. R. Wu-Wong, J. L. Wessale, R. J. Padley, I. R. Garrett, J. M. Chirgwin, and T. A. Guise From the Cover: A causal role for endothelin-1 in the pathogenesis of osteoblastic bone metastases PNAS, September 16, 2003; 100(19): 10954 - 10959. [Abstract] [Full Text] [PDF]

				P. N. Colleran, M. K. Wilkerson, S. A. Bloomfield, L. J. Suva, R. T. Turner, and M. D. Delp Alterations in skeletal perfusion with simulated microgravity: a possible mechanism for bone remodeling J Appl Physiol, September 1, 2000; 89(3): 1046 - 1054. [Abstract] [Full Text] [PDF]

				T. S. Gross, A. A. Damji, S. Judex, R. C. Bray, and R. F. Zernicke Bone hyperemia precedes disuse-induced intracortical bone resorption J Appl Physiol, January 1, 1999; 86(1): 230 - 235. [Abstract] [Full Text] [PDF]

				Y. Hiruma, A. Inoue, A. Shiohama, E. Otsuka, S. Hirose, A. Yamaguchi, and H. Hagiwara Endothelins inhibit the mineralization of osteoblastic MC3T3-E1 cells through the A-type endothelin receptor Am J Physiol Regulatory Integrative Comp Physiol, October 1, 1998; 275(4): R1099 - R1105. [Abstract] [Full Text] [PDF]

				H. J. Leis, D. Zach, E. Huber, and W. Windischhofer Prostaglandin Endoperoxide Synthase-2 Contributes to the Endothelin/Sarafotoxin-Induced Prostaglandin E2 Synthesis in Mouse Osteoblastic Cells (MC3T3-E1): Evidence for a Protein Tyrosine Kinase-Signaling Pathway and Involvement of Protein Kinase C Endocrinology, March 1, 1998; 139(3): 1268 - 1277. [Abstract] [Full Text] [PDF]

				T. A. Guise and G. R. Mundy Cancer and Bone Endocr. Rev., February 1, 1998; 19(1): 18 - 54. [Abstract] [Full Text]